197 related articles for article (PubMed ID: 29310515)
1. Persons with Chronic Spinal Cord Injury Have Decreased Natural Killer Cell and Increased Toll-Like Receptor/Inflammatory Gene Expression.
Herman P; Stein A; Gibbs K; Korsunsky I; Gregersen P; Bloom O
J Neurotrauma; 2018 Aug; 35(15):1819-1829. PubMed ID: 29310515
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study.
Laginha I; Kopp MA; Druschel C; Schaser KD; Brommer B; Hellmann RC; Watzlawick R; Ossami-Saidi RR; Prüss H; Failli V; Meisel C; Liebscher T; Prilipp E; Niedeggen A; Ekkernkamp A; Grittner U; Piper SK; Dirnagl U; Killig M; Romagnani C; Schwab JM
BMC Neurol; 2016 Sep; 16(1):170. PubMed ID: 27618987
[TBL] [Abstract][Full Text] [Related]
3. Systemic gene expression profiles according to pain types in individuals with chronic spinal cord injury.
Morrison D; Arcese AA; Parrish J; Gibbs K; Beaufort A; Herman P; Stein AB; Bloom O
Mol Pain; 2021; 17():17448069211007289. PubMed ID: 33853401
[TBL] [Abstract][Full Text] [Related]
4. Profiling Immunological Phenotypes in Individuals During the First Year After Traumatic Spinal Cord Injury: A Longitudinal Analysis.
Morrison D; Pinpin C; Lee A; Sison C; Chory A; Gregersen PK; Forrest G; Kirshblum S; Harkema SJ; Boakye M; Harrop JS; Bryce TN; Schwab JM; Kwon BK; Stein AB; Bank MA; Bloom O
J Neurotrauma; 2023 Dec; 40(23-24):2621-2637. PubMed ID: 37221869
[No Abstract] [Full Text] [Related]
5. High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury.
Papatheodorou A; Stein A; Bank M; Sison CP; Gibbs K; Davies P; Bloom O
J Neurotrauma; 2017 Feb; 34(3):746-754. PubMed ID: 27673428
[TBL] [Abstract][Full Text] [Related]
6. Role of Toll like receptor 4 signaling pathway in the secondary damage induced by experimental spinal cord injury.
Impellizzeri D; Ahmad A; Di Paola R; Campolo M; Navarra M; Esposito E; Cuzzocrea S
Immunobiology; 2015 Sep; 220(9):1039-49. PubMed ID: 25990044
[TBL] [Abstract][Full Text] [Related]
7. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
Stein A; Panjwani A; Sison C; Rosen L; Chugh R; Metz C; Bank M; Bloom O
Arch Phys Med Rehabil; 2013 Aug; 94(8):1498-507. PubMed ID: 23618747
[TBL] [Abstract][Full Text] [Related]
8. Circulating T cell subsets are altered in individuals with chronic spinal cord injury.
Monahan R; Stein A; Gibbs K; Bank M; Bloom O
Immunol Res; 2015 Dec; 63(1-3):3-10. PubMed ID: 26440591
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pain symptoms and quality of life using the International Spinal Cord Injury Data Sets in persons with chronic spinal cord injury.
Gibbs K; Beaufort A; Stein A; Leung TM; Sison C; Bloom O
Spinal Cord Ser Cases; 2019; 5():32. PubMed ID: 31240125
[TBL] [Abstract][Full Text] [Related]
10. Altered leukocyte gene expression after traumatic spinal cord injury: clinical implications.
Herman PE; Bloom O
Neural Regen Res; 2018 Sep; 13(9):1524-1529. PubMed ID: 30127106
[TBL] [Abstract][Full Text] [Related]
11. Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.
Bracchi-Ricard V; Zha J; Smith A; Lopez-Rodriguez DM; Bethea JR; Andreansky S
J Neuroinflammation; 2016 May; 13(1):125. PubMed ID: 27245318
[TBL] [Abstract][Full Text] [Related]
12. Influence of neurological level on immune function following spinal cord injury: a review.
Campagnolo DI; Bartlett JA; Keller SE
J Spinal Cord Med; 2000; 23(2):121-8. PubMed ID: 10914353
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors in spinal cord injury.
Kigerl KA; Popovich PG
Curr Top Microbiol Immunol; 2009; 336():121-36. PubMed ID: 19688331
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury.
Bank M; Stein A; Sison C; Glazer A; Jassal N; McCarthy D; Shatzer M; Hahn B; Chugh R; Davies P; Bloom O
Arch Phys Med Rehabil; 2015 Apr; 96(4):633-44. PubMed ID: 25461821
[TBL] [Abstract][Full Text] [Related]
15. Spinal Cord Injury Suppresses Cutaneous Inflammation: Implications for Peripheral Wound Healing.
Marbourg JM; Bratasz A; Mo X; Popovich PG
J Neurotrauma; 2017 Mar; 34(6):1149-1155. PubMed ID: 27650169
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions.
Li Z; Wu F; Xu D; Zhi Z; Xu G
Biomed Pharmacother; 2019 Jan; 109():2014-2021. PubMed ID: 30551457
[TBL] [Abstract][Full Text] [Related]
17. TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Church JS; Kigerl KA; Lerch JK; Popovich PG; McTigue DM
J Neurosci; 2016 Jun; 36(23):6352-64. PubMed ID: 27277810
[TBL] [Abstract][Full Text] [Related]
18. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.
Sun X; Jones ZB; Chen XM; Zhou L; So KF; Ren Y
J Neuroinflammation; 2016 Oct; 13(1):260. PubMed ID: 27716334
[TBL] [Abstract][Full Text] [Related]
19. Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction.
Gucluler G; Adiguzel E; Gungor B; Kahraman T; Gursel M; Yilmaz B; Gursel I
PLoS One; 2017; 12(2):e0171003. PubMed ID: 28170444
[TBL] [Abstract][Full Text] [Related]
20. The role of timing in the treatment of spinal cord injury.
Saghazadeh A; Rezaei N
Biomed Pharmacother; 2017 Aug; 92():128-139. PubMed ID: 28535416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
